SEC Filing Timeline
8-KAug 05, 2026
Earnings release · Items 2.02,9.01
10-QAug 05, 2026
Quarterly report
8-KJul 07, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
8-KMay 28, 2026
Shareholder vote results · Items 5.07
8-KMay 13, 2026
Earnings release · Items 2.02,9.01
10-QMay 13, 2026
Quarterly report
DEF 14AApr 15, 2026
Proxy statement
10-KMar 24, 2026
Annual report
8-KMar 24, 2026
Earnings release · Items 2.02,9.01
8-KFeb 19, 2026
Material agreement · Items 1.01,7.01,9.01
424B5Feb 19, 2026
Prospectus / offering
424B5Feb 17, 2026
Prospectus / offering
8-KFeb 17, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
Recent News (Finnhub)
HC Wainwright & Co. Maintains Buy on Compass Pathways, Lowers Price Target to $65
Morgan Stanley Maintains Overweight on Compass Pathways, Raises Price Target to $18
RBC Capital Maintains Outperform on Compass Pathways, Lowers Price Target to $21
B. Riley Securities Maintains Buy on Compass Pathways, Raises Price Target to $22
Compass Pathways Collaborates With U.S. Department Of Veterans Affairs On A Multi-Site Randomized Controlled Clinical Trial
Compass Pathways Files Prospectus For Offering Mixed Shelf; Terms Undisclosed
COMPASS Pathways plc (CMPS) Q2 2026 Earnings Call Transcript
Compass Pathways (NASDAQ:CMPS) Shares Plunge 42% After Q2 Report Despite Narrower-Than-Expected Loss